KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other financing activities (2018 - 2023)

Pacific Biosciences Of California (PACB) has 6 years of Other financing activities data on record, last reported at $50000.0 in Q4 2023.

  • For Q4 2023, Other financing activities changed N/A year-over-year to $50000.0; the TTM value through Dec 2024 reached $539000.0, changed 0.0%, while the annual FY2023 figure was $7.4 million, N/A changed from the prior year.
  • Other financing activities reached $50000.0 in Q4 2023 per PACB's latest filing, down from $489000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $32.2 million in Q4 2020 and bottomed at -$30.4 million in Q4 2021.
  • Average Other financing activities over 5 years is $5.0 million, with a median of $1.0 million recorded in 2019.
  • Peak YoY movement for Other financing activities: skyrocketed 24469.47% in 2020, then crashed 288.41% in 2022.
  • A 5-year view of Other financing activities shows it stood at $131000.0 in 2019, then surged by 24469.47% to $32.2 million in 2020, then plummeted by 194.35% to -$30.4 million in 2021, then surged by 81.59% to -$5.6 million in 2022, then surged by 100.89% to $50000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $50000.0 in Q4 2023, $489000.0 in Q3 2023, and -$5.6 million in Q2 2022.